927673-86-7 Usage
Uses
Used in Pharmaceutical Industry:
3-bromo-6-morpholinopyridazine is utilized as a key building block in the synthesis of various pharmaceuticals due to its unique structure and properties. It plays a crucial role in the development of new therapeutic agents, contributing to the advancement of medicinal chemistry.
Used in Antiviral Research:
3-bromo-6-morpholinopyridazine is studied for its potential antiviral activities, making it a valuable target for research and development in the field of medicinal chemistry. Its antiviral properties could lead to the discovery of new treatments for viral infections.
Used in Anticancer Research:
3-bromo-6-morpholinopyridazine is also being investigated for its potential anticancer activities. The exploration of its anticancer properties aims to contribute to the development of novel cancer therapies, potentially offering new options for patients and healthcare providers.
Check Digit Verification of cas no
The CAS Registry Mumber 927673-86-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,7,6,7 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 927673-86:
(8*9)+(7*2)+(6*7)+(5*6)+(4*7)+(3*3)+(2*8)+(1*6)=217
217 % 10 = 7
So 927673-86-7 is a valid CAS Registry Number.
927673-86-7Relevant academic research and scientific papers
1, 3, 4, 5-TETRAHYDRO-2H-PYRIDO[4,3-B]INDOLE DERIVATIVES FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES LIKE ALZHEIMER'S DISEASE
-
Page/Page column 92, (2019/07/20)
The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
COMBINATION OF CB2 LIGAND AND PARACETAMOL
-
Page/Page column 170, (2008/12/04)
Combination of one or more CB2 modulators and paracetamol are useful of treating conditions which are mediated by the activity of CB2 receptors such as an immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis, and osteoporosis.
PYRIDAZINE DERIVATIVES WITH ANTIINFLAMMATORY ACTIVITY
-
Page/Page column 27-28, (2008/06/13)
The present invention relates to novel pyridazinyl derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrea
